Stuart Burri, M.D.

Dad, husband, Radiation Oncologist with Southeast Radiation Oncology and Levine Cancer Institute @atriumhealth @levinecancer. Of course, the opinions are mine

[Stuart Burri, M.D. @stuxrt]

Excited for the @ASTRO_org Presidential symposium ! @SameerKeoleMD has an action packed slate of fascinating talks on non-malignant disease #ASTRO25

[Dan Trifiletti, MD @DanTrifMD]

🔔⏰ Welcome to #ASTRO2025 ⏰ 🔔

Honored to sit on the stage in front of a big crowd while we learn from @ChristyCramerMD @stuxrt @joshuapalmermd

If you’re on your way get excited, tons of great presentations planned and networking opportunities. And also perfect weather 💪

[Beant Gill @BeantGill118]

PRO sessions in full force here at #ASTRO2025 with more brains 🧠 joining for brain reRT @DanTrifMD @joshuapalmermd @ChristyCramerMD @stuxrt

[Stuart Burri, M.D. @stuxrt]

For those East Coast early risers at #ASTRO25 forget the @rydercup and come over and watch the All-Star panel at the PRO session of @DanTrifMD @joshuapalmermd and @ChristyCramerMD and me discuss re-irradiation of #braintumors (and Mets) plus reduce toxicity @ASTRO_org

[Stuart Burri, M.D. @stuxrt]

@PDBrownOnc Or just treat Pre-op…

[Matthew Ward @MCWardMD]

It was a pleasure working with an all-star team to update the former ACR (now @RadiumSociety) "Appropriate Use" guideline on sinonasal cancer #radonc #hncsm @HeadNeckMD @MargalitMd https://t.co/Imn6YiNqzC

[Ruben A. Mesa, MD @mpdrc]

Congrats on Dr Michael Chan new Chair of #RadOnc for @wakeforestmed WS Campus). Amazing succesor of #WilliamBlackstock as #ServantLeader, #CNS CA leader/educator/@AtriumHealthWFB Comprehensive Cancer Center @DavidZaasMD #DeanBoulware @JFreischlag

[Ruben A. Mesa, MD @mpdrc]

Inspiring retreat at @Kcannonballers for @AtriumHealth @LevineCancer on delivering #LovedOneStandard #CancerCare #BestPlaceToCare @AtriumHealthWFB Comprehensive Cancer Center

@LeonMizrachi @stuxrt @confectionsmd @KatherineAnsley @DiannaSHoward @wakeforestmed @PlasmaCellPete

[OncoAlert @OncoAlert]

Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer out on Lancet Oncology
https://t.co/XcmNCXXMXK

Multicentre, single-arm phase 2 trial evaluated the safety and efficacy of a novel treatment approach for patients with unresectable, locally advanced non-small-cell #LungCancer ( #NSCLC ), involving stereotactic body radiotherapy (SBRT) to the primary tumor, followed by standard chemoradiotherapy to the lymph nodes and consolidation immunotherapy with durvalumab. Sixty-one patients were enrolled, with a median follow-up of 29.5 months. The study reported a 1-year progression-free survival (PFS) of 62.7%, although it did not achieve the primary endpoint of significant improvement over historical controls. Treatment-related grade 3–4 adverse events included decreased neutrophil and white blood cell counts, and treatment-related deaths occurred in 7% of patients. Despite not meeting the primary endpoint, the treatment demonstrated favorable activity and safety profiles, forming the basis for an ongoing randomized phase 3 trial (NRG Oncology LU008).

@DrJRadOnc
@KMilehamMD
@DrChrisCorso
@AKesarwala
@stuxrt

Ping
OncoAlert Rad Onc Faculty
@MKnoll_MD @HenningWillers @fumikochino @_ShankarSiva
@PercyLeeMD @Icro_Meattini @DrChowdharyMD @DrLesterColl @ErinGillespieMD @seanmmcbride @NiuSanford

#OncoAlertAF
@nataliagandur @acampsmalea @BiagioRicciutMD
@yekeduz_emre @HHorinouchi @FadiHaddad_MD
@Dr_Ivanoncologo @Abdallah81MD @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK

[Matthew Ward @MCWardMD]

It’s an honor to care for patients with the support of outstanding organizations like @LevineCancer and @Panthers

[Stuart Burri, M.D. @stuxrt]

Plus in medullo has the theoretical benefit of reducing surgical perturbation failure - much like seems to be the case for brain metastases

[Joshua D. Palmer, MD @joshuapalmermd]

@cristian_udo @MohitKasibhatla @RO_GreenJournal @HaghighiNeda @PeterMacRadOnc @PeterMacCC @PeterMacRes @svporceddu @celloradonc @JMBryantMD @DrPinky_UK @DanTrifMD @MayoClinic @MayoFL_RORes @TheChristieNHS @gerbenborst @stuxrt @ErinMurphyMD @RoshanPrabhu07 Agree I love the idea for other histology, personally I think best for medullo and gbm first but could be good for others. Have seen complete responses in preop for medullo

[Levine Cancer @LevineCancer]

The power of proton is HERE! 🎉
We're proud to be the first & only program in the Carolinas to offer this state-of-the-art treatment. Our first 2 patients, Dakota & Hunter helped us cut the ribbon on this new service today!
Link to learn more: https://t.co/c1sUU455dt

[Ruben A. Mesa, MD @mpdrc]

Day 1 of treating patients with #Protons at the ⁦@AtriumHealth⁩ ⁦@LevineCancer⁩ PARC (Proton & Advanced Radiation Center)- the first Proton Center for the Carolinas ⁦@stuxrt⁩ ⁦@LCHdoctorO⁩ ⁦⁦@LevineChildrens⁩ ⁦@wakeforestmed⁩ ⁦

[Stuart Burri, M.D. @stuxrt]

Thanks to the @Panthers for inviting the @AtriumHealth @LevineCancer team to the #CrucialCatch @BankofAmerica stadium! Amazing event and venue. #KeepPounding

[Stuart Burri, M.D. @stuxrt]

Don’t miss @yoonie_verse and I moderate what promises to be a great session this afternoon @ASTRO_org #ASTRO24 You can be there while I shamelessly plug @NRGonc #BN-012 - plus it’s rainy outside anyway…

[Stuart Burri, M.D. @stuxrt]

Thoroughly enjoyed the #GammaKnife lecture from Roshan Prabhu @Elekta #ASTRO24 illustrating #SRS program growth with a dedicated radiosurgery device @AtriumHealth @ASTRO_org

[Stuart Burri, M.D. @stuxrt]

77.8% PFS at 6 months impressive for 177Lu-Dotatate for recurrent grade II or III meningioma. Potentially exciting new option for difficult to manage patients. #meningioma @PDBrownOnc @wgbreen @NovartisCancer #ASTRO24 @ASTRO_org